BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1706860)

  • 1. [Effectiveness of intravenous immunoglobulins in polymyositis and dermatomyositis. An open trial in 15 patients].
    Cherin P; Herson S; Wechsler B; Piette JC; Bletry O; Degennes C; Ziza JM; Du LT; Godeau P
    Presse Med; 1991 Feb; 20(6):244-9. PubMed ID: 1706860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.
    Cherin P; Herson S; Wechsler B; Piette JC; Bletry O; Coutellier A; Ziza JM; Godeau P
    Am J Med; 1991 Aug; 91(2):162-8. PubMed ID: 1714235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
    Chérin P; Herson S
    Ann Med Interne (Paris); 1993; 144(8):521-5. PubMed ID: 8179241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of polymyositis and dermatomyositis.
    Marie I; Mouthon L
    Autoimmun Rev; 2011 Nov; 11(1):6-13. PubMed ID: 21740984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.
    Cherin P; Pelletier S; Teixeira A; Laforet P; Genereau T; Simon A; Maisonobe T; Eymard B; Herson S
    Arthritis Rheum; 2002 Feb; 46(2):467-74. PubMed ID: 11840450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyositis/dermatomyositis: clinical features and outcome in 22 patients.
    Baron M; Small P
    J Rheumatol; 1985 Apr; 12(2):283-6. PubMed ID: 3875720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovering autonomy is a key advantage of home-based immunoglobulin therapy in patients with myositis: A qualitative research study.
    Chérin P; Pindi Sala T; Clerson P; Dokhan A; Fardini Y; Duracinsky M; Crave JC; Chassany O
    Medicine (Baltimore); 2020 Feb; 99(7):e19012. PubMed ID: 32049796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
    Pongratz D
    J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of polymyositis and dermatomyositis.
    Ansell BM
    Clin Rheum Dis; 1984 Apr; 10(1):205-13. PubMed ID: 6734117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
    Unger L; Kampf S; Lüthke K; Aringer M
    Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatomyositis-polymyositis in children.
    Goel KM; King M
    Scott Med J; 1986 Jan; 31(1):15-9. PubMed ID: 3515551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
    Stoll T; Michel BA; Neidhart M; Wassmer P; Neidl K; Fehr K; Wagenhäuser FJ
    Schweiz Med Wochenschr; 1992 Sep; 122(39):1458-65. PubMed ID: 1411405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of polymyositis and dermatomyositis.
    Kaye SA; Isenberg DA
    Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of polymyositis and dermatomyositis.
    Marie I
    Presse Med; 2011 Apr; 40(4 Pt 2):e257-70. PubMed ID: 21334847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment.
    Ramírez G; Asherson RA; Khamashta MA; Cervera R; D'Cruz D; Hughes GR
    Semin Arthritis Rheum; 1990 Oct; 20(2):114-20. PubMed ID: 2251506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous immunoglobulins in polymyositis and dermatomyositis].
    Chérin P; Herson S
    Rev Med Interne; 1999; 20 Suppl 4():436s-439s. PubMed ID: 10522319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.